Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Feb-24 4:27 PM View:  | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 09-Feb-24 | Option Exercise | 23,557 | $4.31 | $101,531.00 | 3% 677.89K to 701.44K | |
| 12-Feb-24 4:27 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 09-Feb-24 | Planned Option Sale | 23,557 | $45.54 | $1,072,720.00 | (3%) 701.44K to 677.89K | |
| 13-Feb-24 4:59 PM View: | Ruiz Briseno Andres See Remarks | Ideaya Biosciences, Inc. (IDYA) | 09-Feb-24 | Private Sale (Planned) | 2,000 | $46.02 | $92,044.60 | (8%) 26.53K to 24.53K | |
| 12-Feb-24 4:27 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 08-Feb-24 | Option Exercise | 75,815 | $4.31 | $326,763.00 | 11% 677.89K to 753.7K | |
| 12-Feb-24 4:27 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 08-Feb-24 | Planned Option Sale | 75,815 | $45.15 | $3,422,840.00 | (10%) 753.7K to 677.89K | |
| 05-Feb-24 6:05 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 01-Feb-24 | Option Exercise | 628 | $4.31 | $2,706.68 | < 1% 677.89K to 678.51K | |
| 05-Feb-24 6:05 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 01-Feb-24 | Planned Option Sale | 628 | $45.00 | $28,260.00 | (< 1%) 678.51K to 677.89K | |
| 24-Jan-24 7:12 PM View: | Ruiz Briseno Andres See Remarks | Ideaya Biosciences, Inc. (IDYA) | 22-Jan-24 | Private Sale (Planned) | 2,000 | $42.03 | $84,050.20 | (7%) 28.53K to 26.53K | |
| 17-Jan-24 5:40 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 16-Jan-24 | Option Exercise | 62,739 | $4.31 | $270,405.00 | 9% 677.89K to 740.63K | |
| 17-Jan-24 5:40 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 16-Jan-24 | Planned Option Sale | 62,739 | $40.17 | $2,519,970.00 | (8%) 740.63K to 677.89K | |
| 17-Jan-24 5:41 PM View: | Ruiz Briseno Andres See Remarks | Ideaya Biosciences, Inc. (IDYA) | 12-Jan-24 | Private Sale (Planned) | 2,000 | $38.01 | $76,025.60 | (7%) 30.53K to 28.53K | |
| 17-Jan-24 5:40 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 12-Jan-24 | Option Exercise | 12,261 | $4.31 | $52,844.90 | 2% 677.89K to 690.15K | |
| 17-Jan-24 5:40 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 12-Jan-24 | Planned Option Sale | 12,261 | $40.04 | $490,913.00 | (2%) 690.15K to 677.89K | |
| 19-Dec-23 5:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 18-Dec-23 | Option Exercise | 10,000 | $7.01 | $70,100.00 | 100% 0 to 10.0K | |
| 19-Dec-23 5:34 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 15-Dec-23 | Option Exercise | 75,000 | $4.31 | $323,250.00 | 11% 677.89K to 752.89K | |
| 19-Dec-23 5:34 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 15-Dec-23 | Planned Option Sale | 75,000 | $35.03 | $2,627,620.00 | (10%) 752.89K to 677.89K | |
| 19-Dec-23 5:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 15-Dec-23 | Option Exercise | 10,000 | $13.34 | $133,400.00 | 100% 0 to 10.0K | |
| 19-Dec-23 5:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 15-Dec-23 | Planned Option Sale | 10,000 | $35.04 | $350,371.00 | (100%) 10.0K to 0 | |
| 18-Dec-23 5:45 PM View: | Ruiz Briseno Andres See Remarks | Ideaya Biosciences, Inc. (IDYA) | 14-Dec-23 | Private Sale (Planned) | 2,000 | $34.00 | $68,001.60 | (6%) 32.53K to 30.53K | |
| 07-Nov-23 5:47 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 03-Nov-23 | Option Exercise | 5,163 | $12.86 | $66,396.20 | 100% 0 to 5.16K | |
| 07-Nov-23 5:47 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 03-Nov-23 | Planned Option Sale | 5,163 | $30.09 | $155,360.00 | (100%) 5.16K to 0 | |
| 14-Sep-23 5:23 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 12-Sep-23 | Planned Option Sale | 1,000 | $30.00 | $30,005.00 | (100%) 1.0K to 0 | |
| 14-Sep-23 5:23 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 12-Sep-23 | Option Exercise | 1,000 | $12.86 | $12,860.00 | 100% 0 to 1.0K | |
| 06-Sep-23 6:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 05-Sep-23 | Planned Option Sale | 1,737 | $30.03 | $52,159.90 | (100%) 1.74K to 0 | |
| 06-Sep-23 6:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 05-Sep-23 | Option Exercise | 1,737 | $12.86 | $22,337.80 | 100% 0 to 1.74K | |
| 06-Sep-23 6:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 01-Sep-23 | Planned Option Sale | 2,100 | $30.03 | $63,062.60 | (100%) 2.1K to 0 | |
| 06-Sep-23 6:37 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 01-Sep-23 | Option Exercise | 2,100 | $12.86 | $27,006.00 | 100% 0 to 2.1K | |
| 06-Sep-23 6:36 PM View: | Ruiz Briseno Andres See Remarks | Ideaya Biosciences, Inc. (IDYA) | 01-Sep-23 | Private Sale (Planned) | 2,000 | $30.01 | $60,016.00 | (6%) 34.53K to 32.53K | |
| 31-Aug-23 5:49 PM View: | Stone Paul A. Chief Financial Officer | Ideaya Biosciences, Inc. (IDYA) | 29-Aug-23 | Private Sale (Planned) | 5,000 | $28.87 | $144,352.00 | (35%) 14.3K to 9.3K | |
| 23-Aug-23 6:31 PM View: | Stone Paul A. Chief Financial Officer | Ideaya Biosciences, Inc. (IDYA) | 21-Aug-23 | Private Sale (Planned) | 978 | $26.40 | $25,819.50 | (6%) 15.28K to 14.3K | |
| 18-Aug-23 6:33 PM View: | Stone Paul A. Chief Financial Officer | Ideaya Biosciences, Inc. (IDYA) | 18-Aug-23 | Sale (Planned) | 3,822 | $26.38 | $100,820.00 | (20%) 19.1K to 15.28K | |
| 18-Aug-23 6:33 PM View: | Stone Paul A. Chief Financial Officer | Ideaya Biosciences, Inc. (IDYA) | 16-Aug-23 | Private Sale (Planned) | 200 | $26.42 | $5,285.00 | (1%) 19.3K to 19.1K | |
| 11-Aug-23 7:21 PM View: | Stone Paul A. Chief Financial Officer | Ideaya Biosciences, Inc. (IDYA) | 09-Aug-23 | Private Sale (Planned) | 2,500 | $25.05 | $62,613.20 | (11%) 21.8K to 19.3K | |
| 11-Aug-23 7:22 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 09-Aug-23 | Planned Option Sale | 5,000 | $25.09 | $125,430.00 | (100%) 5.0K to 0 | |
| 11-Aug-23 7:22 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 09-Aug-23 | Option Exercise | 5,000 | $13.34 | $66,700.00 | 100% 0 to 5.0K | |
| 12-Jul-23 5:25 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 10-Jul-23 | Planned Option Sale | 9,485 | $23.00 | $218,178.00 | (100%) 9.48K to 0 | |
| 12-Jul-23 5:25 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 10-Jul-23 | Option Exercise | 9,485 | $10.09 | $95,739.90 | 100% 0 to 9.48K | |
| 02-Jun-23 5:29 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 01-Jun-23 | Planned Option Sale | 3,553 | $23.02 | $81,791.80 | (100%) 3.55K to 0 | |
| 02-Jun-23 5:29 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 01-Jun-23 | Option Exercise | 3,553 | $7.01 | $24,906.50 | 100% 0 to 3.55K | |
| 02-Jun-23 5:29 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 31-May-23 | Planned Option Sale | 432 | $23.00 | $9,937.51 | (100%) 0.43K to 0 | |
| 02-Jun-23 5:29 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 31-May-23 | Option Exercise | 432 | $7.01 | $3,028.32 | 100% 0 to 0.43K | |
| 24-May-23 5:51 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 22-May-23 | Planned Option Sale | 500 | $23.00 | $11,500.00 | (100%) 0.5K to 0 | |
| 24-May-23 5:51 PM View: | Throne Jason Chief Legal Officer | Ideaya Biosciences, Inc. (IDYA) | 22-May-23 | Option Exercise | 500 | $7.01 | $3,505.00 | 100% 0 to 0.5K | |
| 14-Apr-23 1:20 PM View: | Stone Paul A. Chief Financial Officer | Ideaya Biosciences, Inc. (IDYA) | 13-Apr-23 | Option Exercise | 8,000 | $4.62 | $36,960.00 | 58% 13.8K to 21.8K | |
| 13-Apr-23 4:11 PM View: | Hata Yujiro S President and CEO Director | Ideaya Biosciences, Inc. (IDYA) | 12-Apr-23 | Option Exercise | 11,601 | $4.31 | $50,000.30 | 2% 666.29K to 677.89K | |
| 07-Oct-21 4:11 PM View: | Dillon Michael P. SVP, Chief Scientific Officer | Ideaya Biosciences, Inc. (IDYA) | 04-Oct-21 | Option Exercise | 1,500 | $11.08 | $16,620.00 | 2% 78.79K to 80.29K | |
| 07-Oct-21 4:11 PM View: | Dillon Michael P. SVP, Chief Scientific Officer | Ideaya Biosciences, Inc. (IDYA) | 04-Oct-21 | Market Option Sale (Planned) | 1,500 | $26.36 | $39,545.00 | (2%) 80.29K to 78.79K | |
| 09-Sep-21 7:24 PM View: | Dillon Michael P. SVP, Chief Scientific Officer | Ideaya Biosciences, Inc. (IDYA) | 08-Sep-21 | Option Exercise | 11,384 | $6.87 | $78,264.00 | 14% 78.79K to 90.17K | |
| 09-Sep-21 7:24 PM View: | Dillon Michael P. SVP, Chief Scientific Officer | Ideaya Biosciences, Inc. (IDYA) | 08-Sep-21 | Market Option Sale (Planned) | 11,384 | $27.42 | $312,093.00 | (13%) 90.17K to 78.79K | |
| 09-Sep-21 7:24 PM View: | Dillon Michael P. SVP, Chief Scientific Officer | Ideaya Biosciences, Inc. (IDYA) | 07-Sep-21 | Market Option Sale (Planned) | 116 | $27.46 | $3,185.00 | (< 1%) 78.91K to 78.79K |
